<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36829952</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3921</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Antioxidants (Basel, Switzerland)</Title><ISOAbbreviation>Antioxidants (Basel)</ISOAbbreviation></Journal><ArticleTitle>Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">393</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antiox12020393</ELocationID><Abstract><AbstractText>Long-term neurological complications, persisting in patients who cannot fully recover several months after severe SARS-CoV-2 coronavirus infection, are referred to as neurological sequelae of the long COVID syndrome. Among the numerous clinical post-acute COVID-19 symptoms, neurological and psychiatric manifestations comprise prolonged fatigue, "brain fog", memory deficits, headache, ageusia, anosmia, myalgias, cognitive impairments, anxiety, and depression lasting several months. Considering that neurons are highly vulnerable to inflammatory and oxidative stress damages following the overproduction of reactive oxygen species (ROS), neuroinflammation and oxidative stress have been suggested to dominate the pathophysiological mechanisms of the long COVID syndrome. It is emphasized that mitochondrial dysfunction and oxidative stress damages are crucial for the pathogenesis of neurodegenerative disorders. Importantly, antioxidant therapies have the potential to slow down and prevent disease progression. However, many antioxidant compounds display low bioavailability, instability, and transport to targeted tissues, limiting their clinical applications. Various nanocarrier types, e.g., liposomes, cubosomes, solid lipid nanoparticles, micelles, dendrimers, carbon-based nanostructures, nanoceria, and other inorganic nanoparticles, can be employed to enhance antioxidant bioavailability. Here, we highlight the potential of phytochemical antioxidants and other neuroprotective agents (curcumin, quercetin, vitamins C, E and D, melatonin, rosmarinic acid, N-acetylcysteine, and Ginkgo Biloba derivatives) in therapeutic strategies for neuroregeneration. A particular focus is given to the beneficial role of nanoparticle-mediated drug-delivery systems in addressing the challenges of antioxidants for managing and preventing neurological disorders as factors of long COVID sequelae.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akanchise</LastName><ForeName>Thelma</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelova</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0285-0637</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antioxidants (Basel)</MedlineTA><NlmUniqueID>101668981</NlmUniqueID><ISSNLinking>2076-3921</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ROS</Keyword><Keyword MajorTopicYN="N">antioxidant-delivery nanosystems</Keyword><Keyword MajorTopicYN="N">lipid nanocarriers</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neurological long COVID-19</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36829952</ArticleId><ArticleId IdType="pmc">PMC9952277</ArticleId><ArticleId IdType="doi">10.3390/antiox12020393</ArticleId><ArticleId IdType="pii">antiox12020393</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nuzzo D., Picone P. Potential Neurological Effects of Severe COVID-19 Infection. Neurosci. Res. 2020;158:1&#x2013;5. doi: 10.1016/j.neures.2020.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2020.06.009</ArticleId><ArticleId IdType="pmc">PMC7333632</ArticleId><ArticleId IdType="pubmed">32628969</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.-I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological Manifestations of Long-COVID Syndrome: A Narrative Review. Ther. Adv. Chronic Dis. 2022;13:204062232210768. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey A.K., Chaudhry S.K., Singh H.B., Gupta V.K., Kaushik A. Perspectives on Nano-Nutraceuticals to Manage Pre and Post COVID-19 Infections. Biotechnol. Rep. 2022;33:e00712. doi: 10.1016/j.btre.2022.e00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.btre.2022.e00712</ArticleId><ArticleId IdType="pmc">PMC8832856</ArticleId><ArticleId IdType="pubmed">35186674</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome. ACS Chem. Neurosci. 2020;11:4017&#x2013;4020. doi: 10.1021/acschemneuro.0c00725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00725</ArticleId><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bratosiewicz-W&#x105;sik J. Neuro-COVID-19: An Insidious Virus in Action. Neurol. Neurochir. Pol. 2022;56:48&#x2013;60. doi: 10.5603/PJNNS.a2021.0072.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/PJNNS.a2021.0072</ArticleId><ArticleId IdType="pubmed">34642927</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T., Trudler D., Oh C.-K., Lipton S.A. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer&#x2019;s Disease, Parkinson&#x2019;s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants. 2022;11:124. doi: 10.3390/antiox11010124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11010124</ArticleId><ArticleId IdType="pmc">PMC8772720</ArticleId><ArticleId IdType="pubmed">35052628</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A., Lyoubi A., Peiffer-Smadja N., de Broucker T., Meppiel E. Neurological Manifestations Associated with SARS-CoV-2 and Other Coronaviruses: A Narrative Review for Clinicians. Rev. Neurol. 2021;177:51&#x2013;64. doi: 10.1016/j.neurol.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Edinoff A.N., Chappidi M., Alpaugh E.S., Turbeville B.C., Falgoust E.P., Cornett E.M., Murnane K.S., Kaye A.M., Kaye A.D. Neurological and Psychiatric Symptoms of COVID-19: A Narrative Review. Psychiatry Int. 2022;3:158&#x2013;168. doi: 10.3390/psychiatryint3020013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/psychiatryint3020013</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., for the Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, Co-Occurrence, and Evolution of Long-COVID Features: A 6-Month Retrospective Cohort Study of 273,618 Survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID Endotheliopathy: Hypothesized Mechanisms and Potential Therapeutic Approaches. J. Clin. Investig. 2022;132:e161167. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S., Williams M.A. Confronting Our Next National Health Disaster&#x2014;Long-Haul COVID. N. Engl. J. Med. 2021;385:577&#x2013;579. doi: 10.1056/NEJMp2109285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Gholami M., Safari S., Ulloa L., Motaghinejad M. Neuropathies and Neurological Dysfunction Induced by Coronaviruses. J. Neurovirol. 2021;27:380&#x2013;396. doi: 10.1007/s13365-021-00977-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00977-x</ArticleId><ArticleId IdType="pmc">PMC8117458</ArticleId><ArticleId IdType="pubmed">33983506</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020;77:1018. doi: 10.1001/jamaneurol.2020.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrzejewski K., Jampolska M., Zaremba M., Joniec-Maciejak I., Boguszewski P.M., Kaczy&#x144;ska K. Respiratory Pattern and Phrenic and Hypoglossal Nerve Activity during Normoxia and Hypoxia in 6-OHDA-Induced Bilateral Model of Parkinson&#x2019;s Disease. J. Physiol. Sci. 2020;70:16. doi: 10.1186/s12576-020-00743-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12576-020-00743-4</ArticleId><ArticleId IdType="pmc">PMC7066294</ArticleId><ArticleId IdType="pubmed">32160868</ArticleId></ArticleIdList></Reference><Reference><Citation>Deumens R., Blokland A., Prickaerts J. Modeling Parkinson&#x2019;s Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway. Exp. Neurol. 2002;175:303&#x2013;317. doi: 10.1006/exnr.2002.7891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2002.7891</ArticleId><ArticleId IdType="pubmed">12061862</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennisi M., Lanza G., Falzone L., Fisicaro F., Ferri R., Bella R. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms. IJMS. 2020;21:5475. doi: 10.3390/ijms21155475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155475</ArticleId><ArticleId IdType="pmc">PMC7432482</ArticleId><ArticleId IdType="pubmed">32751841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zhang Y., Wu L., Niu S., Song C., Zhang Z., Lu G., Qiao C., Hu Y., Yuen K.-Y., et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020;181:894&#x2013;904.e9. doi: 10.1016/j.cell.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Lazartigues E. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus. Cell. Mol. Neurobiol. 2022;42:305&#x2013;309. doi: 10.1007/s10571-020-00915-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00915-1</ArticleId><ArticleId IdType="pmc">PMC7334623</ArticleId><ArticleId IdType="pubmed">32623546</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front. Pharmacol. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Briguglio M., Bona A., Porta M., Dell&#x2019;Osso B., Pregliasco F.E., Banfi G. Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes. Front. Physiol. 2020;11:671. doi: 10.3389/fphys.2020.00671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00671</ArticleId><ArticleId IdType="pmc">PMC7292028</ArticleId><ArticleId IdType="pubmed">32581854</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A., Calvani R., Coelho-Junior H.J., Landi F., Bernabei R., Marzetti E. Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. Antioxidants. 2020;9:647. doi: 10.3390/antiox9080647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9080647</ArticleId><ArticleId IdType="pmc">PMC7466131</ArticleId><ArticleId IdType="pubmed">32707949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliss A., Kuzmin A.N., Prasad P.N., Mahajan S.D. Mitochondrial Dysfunction: A Prelude to Neuropathogenesis of SARS-CoV-2. ACS Chem. Neurosci. 2022;13:308&#x2013;312. doi: 10.1021/acschemneuro.1c00675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00675</ArticleId><ArticleId IdType="pmc">PMC8790819</ArticleId><ArticleId IdType="pubmed">35049274</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Arrigo J.S. Nanotargeting of Drug(s) for Delaying Dementia: Relevance of COVID-19 Impact on Dementia. Am. J. Alzheimers Dis. Other Demen. 2020;35:153331752097676. doi: 10.1177/1533317520976761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317520976761</ArticleId><ArticleId IdType="pmc">PMC10623919</ArticleId><ArticleId IdType="pubmed">33307726</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y.-W., Xu H.-S., Liu S.-J. COVID-19 and Neurodegenerative Diseases. Eur. Rev. Med. Pharmacol. Sci. 2022;26:4535&#x2013;4544. doi: 10.26355/eurrev_202206_29093.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202206_29093</ArticleId><ArticleId IdType="pubmed">35776055</ArticleId></ArticleIdList></Reference><Reference><Citation>Farheen S., Agrawal S., Zubair S., Agrawal A., Jamal F., Altaf I., Kashif Anwar A., Umair S.M., Owais M. Patho-Physiology of Aging and Immune-Senescence: Possible Correlates With Comorbidity and Mortality in Middle-Aged and Old COVID-19 Patients. Front. Aging. 2021;2:748591. doi: 10.3389/fragi.2021.748591.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fragi.2021.748591</ArticleId><ArticleId IdType="pmc">PMC9261314</ArticleId><ArticleId IdType="pubmed">35822018</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe1;rdenas-Rodr&#xed;guez N., Bandala C., Vanoye-Carlo A., Ignacio-Mej&#xed;a I., G&#xf3;mez-Manzo S., Hern&#xe1;ndez-Cruz E.Y., Pedraza-Chaverri J., Carmona-Aparicio L., Hern&#xe1;ndez-Ochoa B. Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19. Antioxidants. 2021;10:971. doi: 10.3390/antiox10060971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10060971</ArticleId><ArticleId IdType="pmc">PMC8235474</ArticleId><ArticleId IdType="pubmed">34204362</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M., Angelov B., Garamus V.M., Angelova A. Curcumin- and Fish Oil-Loaded Spongosome and Cubosome Nanoparticles with Neuroprotective Potential against H 2 O 2 -Induced Oxidative Stress in Differentiated Human SH-SY5Y Cells. ACS Omega. 2019;4:3061&#x2013;3073. doi: 10.1021/acsomega.8b03101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.8b03101</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray B., Bisht S., Maitra A., Maitra A., Lahiri D.K. Neuroprotective and Neurorescue Effects of a Novel Polymeric Nanoparticle Formulation of Curcumin (NanoCurcTM) in the Neuronal Cell Culture and Animal Model: Implications for Alzheimer&#x2019;s Disease. JAD. 2011;23:61&#x2013;77. doi: 10.3233/JAD-2010-101374.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-101374</ArticleId><ArticleId IdType="pmc">PMC3303195</ArticleId><ArticleId IdType="pubmed">20930270</ArticleId></ArticleIdList></Reference><Reference><Citation>Doggui S., Sahni J.K., Arseneault M., Dao L., Ramassamy C. Neuronal Uptake and Neuroprotective Effect of Curcumin-Loaded PLGA Nanoparticles on the Human SK-N-SH Cell Line. JAD. 2012;30:377&#x2013;392. doi: 10.3233/JAD-2012-112141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-112141</ArticleId><ArticleId IdType="pubmed">22426019</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafini M.M., Catanzaro M., Rosini M., Racchi M., Lanni C. Curcumin in Alzheimer&#x2019;s Disease: Can We Think to New Strategies and Perspectives for This Molecule? Pharmacol. Res. 2017;124:146&#x2013;155. doi: 10.1016/j.phrs.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2017.08.004</ArticleId><ArticleId IdType="pubmed">28811228</ArticleId></ArticleIdList></Reference><Reference><Citation>Feitosa E.L., J&#xfa;nior F.T.D.S.S., Nery Neto J.A.D.O., Matos L.F.L., Moura M.H.D.S., Rosales T.O., De Freitas G.B.L. COVID-19: Rational Discovery of the Therapeutic Potential of Melatonin as a SARS-CoV-2 Main Protease Inhibitor. Int. J. Med. Sci. 2020;17:2133&#x2013;2146. doi: 10.7150/ijms.48053.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.48053</ArticleId><ArticleId IdType="pmc">PMC7484667</ArticleId><ArticleId IdType="pubmed">32922174</ArticleId></ArticleIdList></Reference><Reference><Citation>Shneider A., Kudriavtsev A., Vakhrusheva A. Can Melatonin Reduce the Severity of COVID-19 Pandemic? Int. Rev. Immunol. 2020;39:153&#x2013;162. doi: 10.1080/08830185.2020.1756284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830185.2020.1756284</ArticleId><ArticleId IdType="pubmed">32347747</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M., Angelov B., Espinoza S., Khakurel K., Bizien T., Drechsler M., Angelova A. Composition-Switchable Liquid Crystalline Nanostructures as Green Formulations of Curcumin and Fish Oil. ACS Sustain. Chem. Eng. 2021;9:14821&#x2013;14835. doi: 10.1021/acssuschemeng.1c04706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acssuschemeng.1c04706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L., Zheng B., Zhang R., Zhang Z., Liu W., Liu C., Zhang G., Xiao H., McClements D.J. Influence of Lipid Phase Composition of Excipient Emulsions on Curcumin Solubility, Stability, and Bioaccessibility. Food Biophys. 2016;11:213&#x2013;225. doi: 10.1007/s11483-016-9432-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11483-016-9432-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghmur A., Mu H. Recent Advances in Drug Delivery Applications of Cubosomes, Hexosomes, and Solid Lipid Nanoparticles. Acta Pharm. Sin. B. 2021;11:871&#x2013;885. doi: 10.1016/j.apsb.2021.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.02.013</ArticleId><ArticleId IdType="pmc">PMC8105777</ArticleId><ArticleId IdType="pubmed">33996404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai J., Fan B., Thang S.H., Drummond C.J. Novel Amphiphilic Block Copolymers for the Formation of Stimuli-Responsive Non-Lamellar Lipid Nanoparticles. Molecules. 2021;26:3648. doi: 10.3390/molecules26123648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26123648</ArticleId><ArticleId IdType="pmc">PMC8232580</ArticleId><ArticleId IdType="pubmed">34203820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M., Angelov B., Drechsler M., Nicolas V., Bizien T., Gorshkova Y.E., Deng Y., Angelova A. Liquid Crystalline Lipid Nanoparticles for Combined Delivery of Curcumin, Fish Oil and BDNF: In Vitro Neuroprotective Potential in a Cellular Model of Tunicamycin-Induced Endoplasmic Reticulum Stress. Smart Mater. Med. 2022;3:274&#x2013;288. doi: 10.1016/j.smaim.2022.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smaim.2022.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M.A., Jabir N.R., Tabrez S., Ashraf G.M., Shakil S., Damanhouri G.A. Nanotechnology-Based Approaches in Anticancer Research. IJN. 2012;7:4391&#x2013;4408. doi: 10.2147/IJN.S33838.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S33838</ArticleId><ArticleId IdType="pmc">PMC3420598</ArticleId><ArticleId IdType="pubmed">22927757</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang K., Yu J., Howard D., French L., Chen Z., Wen C., Xu Z. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in Human and Mouse Brain. Font. Neurol. 2021;11:573095. doi: 10.3389/fneur.2020.573095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J., Pogue A., Hill J.M. SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cell Mol Neurobiol. 2022;42:217&#x2013;224. doi: 10.1007/s10571-020-00947-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00947-7</ArticleId><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. 18F-FDG Brain PET Hypometabolism in Patients with Long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Arnold A.C., Barboi A., Claydon V.E., Limberg J.K., Lucci V.-E.M., Numan M., Peltier A., Snapper H., Vernino S., et al. Long-COVID Postural Tachycardia Syndrome: An American Autonomic Society Statement. Clin. Auton. Res. 2021;31:365&#x2013;368. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M., St&#xe5;hlberg M., Runold M., Nygren-Bonnier M., Nilsson J., Olshansky B., Bruchfeld J., Fedorowski A. Long-Haul Post&#x2013;COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome. JACC Case Rep. 2021;3:573&#x2013;580. doi: 10.1016/j.jaccas.2021.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2021.01.009</ArticleId><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins J. Preventing a COVID-19 Pandemic. BMJ. 2020;368:m810. doi: 10.1136/bmj.m810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m810</ArticleId><ArticleId IdType="pubmed">32111649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziebuhr J. Molecular Biology of Severe Acute Respiratory Syndrome Coronavirus. Curr. Opin. Microbiol. 2004;7:412&#x2013;419. doi: 10.1016/j.mib.2004.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2004.06.007</ArticleId><ArticleId IdType="pmc">PMC7108451</ArticleId><ArticleId IdType="pubmed">15358261</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel &#xc9;.B. COVID-19: Angiotensin-Converting Enzyme 2 (ACE2) Expression and Tissue Susceptibility to SARS-CoV-2 Infection. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:905&#x2013;919. doi: 10.1007/s10096-020-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohishi M., Yamamoto K., Rakugi H. Angiotensin (1-7) and Other Angiotensin Peptides. CPD. 2013;19:3060&#x2013;3064. doi: 10.2174/1381612811319170013.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612811319170013</ArticleId><ArticleId IdType="pubmed">23176220</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao H., Lan D., Duan Z., Liu Z., Min J., Zhang L., Huang J., Su J., Chen S., Xu A. Upregulation of Mitochondrial Gene Expression in PBMC from Convalescent SARS Patients. J. Clin. Immunol. 2006;26:546&#x2013;554. doi: 10.1007/s10875-006-9046-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-006-9046-y</ArticleId><ArticleId IdType="pmc">PMC7086694</ArticleId><ArticleId IdType="pubmed">17024565</ArticleId></ArticleIdList></Reference><Reference><Citation>Houser M.C., Tansey M.G. The Gut-Brain Axis: Is Intestinal Inflammation a Silent Driver of Parkinson&#x2019;s Disease Pathogenesis? NPJ Park. Dis. 2017;3:3. doi: 10.1038/s41531-016-0002-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-016-0002-0</ArticleId><ArticleId IdType="pmc">PMC5445611</ArticleId><ArticleId IdType="pubmed">28649603</ArticleId></ArticleIdList></Reference><Reference><Citation>Panzarini E., Mariano S., Tacconi S., Carata E., Tata A.M., Dini L. Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders. Nanomaterials. 2020;11:2. doi: 10.3390/nano11010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nano11010002</ArticleId><ArticleId IdType="pmc">PMC7822042</ArticleId><ArticleId IdType="pubmed">33374979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringman J.M., Frautschy S.A., Teng E., Begum A.N., Bardens J., Beigi M., Gylys K.H., Badmaev V., Heath D.D., Apostolova L.G., et al. Oral Curcumin for Alzheimer&#x2019;s Disease: Tolerability and Efficacy in a 24-Week Randomized, Double Blind, Placebo-Controlled Study. Alzheimers Res. 2012;4:43. doi: 10.1186/alzrt146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt146</ArticleId><ArticleId IdType="pmc">PMC3580400</ArticleId><ArticleId IdType="pubmed">23107780</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss D.M., Curley P., Kinvig H., Hoskins C., Owen A. The Biological Challenges and Pharmacological Opportunities of Orally Administered Nanomedicine Delivery. Expert Rev. Gastroenterol. Hepatol. 2018;12:223&#x2013;236. doi: 10.1080/17474124.2018.1399794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17474124.2018.1399794</ArticleId><ArticleId IdType="pubmed">29088978</ArticleId></ArticleIdList></Reference><Reference><Citation>Smoliga J., Blanchard O. Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability Is the Problem, What Is the Solution? Molecules. 2014;19:17154&#x2013;17172. doi: 10.3390/molecules191117154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules191117154</ArticleId><ArticleId IdType="pmc">PMC6270951</ArticleId><ArticleId IdType="pubmed">25347459</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon C., Patel A.A. Organic and Inorganic Nanoparticle Vaccines for Prevention of Infectious Diseases. Nano Express. 2020;1:012001. doi: 10.1088/2632-959X/ab8075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/2632-959X/ab8075</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelov B., Angelova A., Garamus V.M., Drechsler M., Willumeit R., Mutafchieva R., &#x160;t&#x11b;p&#xe1;nek P., Lesieur S. Earliest Stage of the Tetrahedral Nanochannel Formation in Cubosome Particles from Unilamellar Nanovesicles. Langmuir. 2012;28:16647&#x2013;16655. doi: 10.1021/la302721n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/la302721n</ArticleId><ArticleId IdType="pubmed">23148665</ArticleId></ArticleIdList></Reference><Reference><Citation>Scioli Montoto S., Muraca G., Ruiz M.E. Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects. Front. Mol. Biosci. 2020;7:587997. doi: 10.3389/fmolb.2020.587997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.587997</ArticleId><ArticleId IdType="pmc">PMC7662460</ArticleId><ArticleId IdType="pubmed">33195435</ArticleId></ArticleIdList></Reference><Reference><Citation>Husseini G.A., Pitt W.G. Micelles and Nanoparticles for Ultrasonic Drug and Gene Delivery. Adv. Drug Deliv. Rev. 2008;60:1137&#x2013;1152. doi: 10.1016/j.addr.2008.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2008.03.008</ArticleId><ArticleId IdType="pmc">PMC2490710</ArticleId><ArticleId IdType="pubmed">18486269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zieli&#x144;ska A., Carreir&#xf3; F., Oliveira A.M., Neves A., Pires B., Venkatesh D.N., Durazzo A., Lucarini M., Eder P., Silva A.M., et al. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules. 2020;25:3731. doi: 10.3390/molecules25163731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25163731</ArticleId><ArticleId IdType="pmc">PMC7464532</ArticleId><ArticleId IdType="pubmed">32824172</ArticleId></ArticleIdList></Reference><Reference><Citation>Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable Polymeric Nanoparticles as Drug Delivery Devices. J. Control. Release. 2001;70:1&#x2013;20. doi: 10.1016/S0168-3659(00)00339-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-3659(00)00339-4</ArticleId><ArticleId IdType="pubmed">11166403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano A., S&#xe1;nchez-L&#xf3;pez E., Ettcheto M., L&#xf3;pez-Machado A., Espina M., Souto E.B., Galindo R., Camins A., Garc&#xed;a M.L., Turowski P. Current Advances in the Development of Novel Polymeric Nanoparticles for the Treatment of Neurodegenerative Diseases. Nanomedicine. 2020;15:1239&#x2013;1261. doi: 10.2217/nnm-2019-0443.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nnm-2019-0443</ArticleId><ArticleId IdType="pubmed">32370600</ArticleId></ArticleIdList></Reference><Reference><Citation>Giner-Casares J.J., Henriksen-Lacey M., Coronado-Puchau M., Liz-Marz&#xe1;n L.M. Inorganic Nanoparticles for Biomedicine: Where Materials Scientists Meet Medical Research. Mater. Today. 2016;19:19&#x2013;28. doi: 10.1016/j.mattod.2015.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mattod.2015.07.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M., Wang T., Li L., Li X., Zhai Y., Zhang J., Li W. The Application of Inorganic Nanoparticles in Molecular Targeted Cancer Therapy: EGFR Targeting. Front. Pharmacol. 2021;12:702445. doi: 10.3389/fphar.2021.702445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.702445</ArticleId><ArticleId IdType="pmc">PMC8311435</ArticleId><ArticleId IdType="pubmed">34322025</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M., Angelova A. Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders. Medicines. 2018;5:126. doi: 10.3390/medicines5040126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicines5040126</ArticleId><ArticleId IdType="pmc">PMC6313553</ArticleId><ArticleId IdType="pubmed">30477087</ArticleId></ArticleIdList></Reference><Reference><Citation>Dourado D., Freire D.T., Pereira D.T., Amaral-Machado L., Alencar &#xc9;.N., de Barros A.L.B., Egito E.S.T. Will Curcumin Nanosystems Be the next Promising Antiviral Alternatives in COVID-19 Treatment Trials? Biomed. Pharmacother. 2021;139:111578. doi: 10.1016/j.biopha.2021.111578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111578</ArticleId><ArticleId IdType="pmc">PMC8023207</ArticleId><ArticleId IdType="pubmed">33848774</ArticleId></ArticleIdList></Reference><Reference><Citation>Valizadeh H., Abdolmohammadi-vahid S., Danshina S., Ziya Gencer M., Ammari A., Sadeghi A., Roshangar L., Aslani S., Esmaeilzadeh A., Ghaebi M., et al. Nano-Curcumin Therapy, a Promising Method in Modulating Inflammatory Cytokines in COVID-19 Patients. Int. Immunopharmacol. 2020;89:107088. doi: 10.1016/j.intimp.2020.107088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107088</ArticleId><ArticleId IdType="pmc">PMC7574843</ArticleId><ArticleId IdType="pubmed">33129099</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo X., Zhang Y., Jin X., Li Y., Zhang L. A Novel Synthesis of Selenium Nanoparticles Encapsulated PLGA Nanospheres with Curcumin Molecules for the Inhibition of Amyloid &#x3b2; Aggregation in Alzheimer&#x2019;s Disease. J. Photochem. Photobiol. B Biol. 2019;190:98&#x2013;102. doi: 10.1016/j.jphotobiol.2018.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphotobiol.2018.11.008</ArticleId><ArticleId IdType="pubmed">30504054</ArticleId></ArticleIdList></Reference><Reference><Citation>Soleimani V., Sahebkar A., Hosseinzadeh H. Turmeric (Curcuma Longa) and Its Major Constituent (Curcumin) as Nontoxic and Safe Substances: Review. Phytother. Res. 2018;32:985&#x2013;995. doi: 10.1002/ptr.6054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6054</ArticleId><ArticleId IdType="pubmed">29480523</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahedipour F., Hosseini S.A., Sathyapalan T., Majeed M., Jamialahmadi T., Al-Rasadi K., Banach M., Sahebkar A. Potential Effects of Curcumin in the Treatment of COVID -19 Infection. Phytother. Res. 2020;34:2911&#x2013;2920. doi: 10.1002/ptr.6738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6738</ArticleId><ArticleId IdType="pmc">PMC7276879</ArticleId><ArticleId IdType="pubmed">32430996</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Wang W., Sun Y.J., Hu M., Li F., Zhu D.Y. Neuroprotective Effect of Curcumin on Focal Cerebral Ischemic Rats by Preventing Blood&#x2013;Brain Barrier Damage. Eur. J. Pharmacol. 2007;561:54&#x2013;62. doi: 10.1016/j.ejphar.2006.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2006.12.028</ArticleId><ArticleId IdType="pubmed">17303117</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooqui A.A. Curcumin for Neurological and Psychiatric Disorders. Elsevier; London, UK: 2019. Curcumin in Neurological Disorders; pp. 45&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-815461-8.00003-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang X., Wang L., Li J., Wu D. Analysis of Anti-Depressant Potential of Curcumin against Depression Induced Male Albino Wistar Rats. Brain Res. 2016;1642:219&#x2013;225. doi: 10.1016/j.brainres.2016.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.03.010</ArticleId><ArticleId IdType="pubmed">26972530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabot A.B., Huntwork M.P. Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia. Cureus. 2021;13:e17829. doi: 10.7759/cureus.17829.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.17829</ArticleId><ArticleId IdType="pmc">PMC8502749</ArticleId><ArticleId IdType="pubmed">34660038</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripodo G., Chlapanidas T., Perteghella S., Vigani B., Mandracchia D., Trapani A., Galuzzi M., Tosca M.C., Antonioli B., Gaetani P., et al. Mesenchymal Stromal Cells Loading Curcumin-INVITE-Micelles: A Drug Delivery System for Neurodegenerative Diseases. Colloids Surf. B Biointerfaces. 2015;125:300&#x2013;308. doi: 10.1016/j.colsurfb.2014.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.colsurfb.2014.11.034</ArticleId><ArticleId IdType="pubmed">25524221</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S., Zheng Y., Liu X., Fang W., Chen X., Liao W., Jing X., Lei M., Tao E., Ma Q., et al. Curcumin-Loaded PLGA-PEG Nanoparticles Conjugated with B6 Peptide for Potential Use in Alzheimer&#x2019;s Disease. Drug Deliv. 2018;25:1091&#x2013;1102. doi: 10.1080/10717544.2018.1461955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10717544.2018.1461955</ArticleId><ArticleId IdType="pmc">PMC6116673</ArticleId><ArticleId IdType="pubmed">30107760</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rooy I., Mastrobattista E., Storm G., Hennink W.E., Schiffelers R.M. Comparison of Five Different Targeting Ligands to Enhance Accumulation of Liposomes into the Brain. J. Control. Release. 2011;150:30&#x2013;36. doi: 10.1016/j.jconrel.2010.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2010.11.014</ArticleId><ArticleId IdType="pubmed">21087646</ArticleId></ArticleIdList></Reference><Reference><Citation>Prades R., Guerrero S., Araya E., Molina C., Salas E., Zurita E., Selva J., Egea G., L&#xf3;pez-Iglesias C., Teixid&#xf3; M., et al. Delivery of Gold Nanoparticles to the Brain by Conjugation with a Peptide That Recognizes the Transferrin Receptor. Biomaterials. 2012;33:7194&#x2013;7205. doi: 10.1016/j.biomaterials.2012.06.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2012.06.063</ArticleId><ArticleId IdType="pubmed">22795856</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Anderson B., Mao Q., Davidson B.L. Recombinant Human Adenovirus: Targeting to the Human Transferrin Receptor Improves Gene Transfer to Brain Microcapillary Endothelium. J. Virol. 2000;74:11359&#x2013;11366. doi: 10.1128/JVI.74.23.11359-11366.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.23.11359-11366.2000</ArticleId><ArticleId IdType="pmc">PMC113241</ArticleId><ArticleId IdType="pubmed">11070036</ArticleId></ArticleIdList></Reference><Reference><Citation>Urnauer S., Klutz K., Gr&#xfc;nwald G.K., Morys S., Schwenk N., Zach C., Gildehaus F.-J., R&#xf6;dl W., Ogris M., Wagner E., et al. Systemic Tumor-Targeted Sodium Iodide Symporter (NIS) Gene Therapy of Hepatocellular Carcinoma Mediated by B6 Peptide Polyplexes. J. Gene Med. 2017;19:e2957. doi: 10.1002/jgm.2957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgm.2957</ArticleId><ArticleId IdType="pubmed">28423213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin T., Yang L., Liu Y., Zhou X., Sun J., Liu J. Sialic Acid (SA)-Modified Selenium Nanoparticles Coated with a High Blood&#x2013;Brain Barrier Permeability Peptide-B6 Peptide for Potential Use in Alzheimer&#x2019;s Disease. Acta Biomater. 2015;25:172&#x2013;183. doi: 10.1016/j.actbio.2015.06.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actbio.2015.06.035</ArticleId><ArticleId IdType="pubmed">26143603</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalfenberg G.K. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks) J. Nutr. Metab. 2021;2021:1&#x2013;13. doi: 10.1155/2021/9949453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9949453</ArticleId><ArticleId IdType="pmc">PMC8211525</ArticleId><ArticleId IdType="pubmed">34221501</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;alamon &#x160;., Kramar B., Marolt T.P., Polj&#x161;ak B., Milisav I. Medical and Dietary Uses of N-Acetylcysteine. Antioxidants. 2019;8:111. doi: 10.3390/antiox8050111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8050111</ArticleId><ArticleId IdType="pmc">PMC6562654</ArticleId><ArticleId IdType="pubmed">31035402</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadowska A.M., Verbraecken J., Darquennes K., Backer W.D. Role of N-Acetylcysteine in the Management of COPD. Int. J. COPD. 2006;1:425&#x2013;434. doi: 10.2147/copd.2006.1.4.425.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/copd.2006.1.4.425</ArticleId><ArticleId IdType="pmc">PMC2707813</ArticleId><ArticleId IdType="pubmed">18044098</ArticleId></ArticleIdList></Reference><Reference><Citation>Radomska-Le&#x15b;niewska D.M., Skopi&#x144;ska-R&#xf3;&#x17c;ewska E., Jankowska-Steifer E., Sobiecka M., Sadowska A.M., Hevelke A., Malejczyk J. N-Acetylcysteine Inhibits IL-8 and MMP-9 Release and ICAM-1 Expression by Bronchoalveolar Cells from Interstitial Lung Disease Patients. Pharmacol. Rep. 2010;62:131&#x2013;138. doi: 10.1016/S1734-1140(10)70250-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1734-1140(10)70250-4</ArticleId><ArticleId IdType="pubmed">20360623</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafarullah M., Li W.Q., Sylvester J., Ahmad M. Molecular Mechanisms of N -Acetylcysteine Actions. Cell. Mol. Life Sci. (CMLS) 2003;60:6&#x2013;20. doi: 10.1007/s000180300001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000180300001</ArticleId><ArticleId IdType="pmc">PMC11138873</ArticleId><ArticleId IdType="pubmed">12613655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavarsad Shahripour R., Harrigan M.R., Alexandrov A.V. N-acetylcysteine (NAC) in Neurological Disorders: Mechanisms of Action and Therapeutic Opportunities. Brain Behav. 2014;4:108&#x2013;122. doi: 10.1002/brb3.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.208</ArticleId><ArticleId IdType="pmc">PMC3967529</ArticleId><ArticleId IdType="pubmed">24683506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Ren Q., Zhang J., Ye Y., Zhang Z., Xu Y., Guo M., Ji H., Xu C., Gu C., et al. N-Acetyl-L-Cysteine Protects against Cadmium-Induced Neuronal Apoptosis by Inhibiting ROS-Dependent Activation of Akt/MTOR Pathway in Mouse Brain: NAC Prevents Cd Neurotoxicity via Targeting ROS-MTOR Signalling. Neuropathol. Appl. Neurobiol. 2014;40:759&#x2013;777. doi: 10.1111/nan.12103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12103</ArticleId><ArticleId IdType="pmc">PMC4043941</ArticleId><ArticleId IdType="pubmed">24299490</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan A.C., Wong C. Chronic Fatigue Syndrome: Oxidative Stress and Dietary Modifications. Altern. Med. Rev. 2001;6:450&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">11703165</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Quach T., Tiwari A., Bonilla A., Miglis M., Yang P., Eggert L., Sharifi H., Horomanski A., Subramanian A., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Is Common in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): Results from a Post-COVID-19 Multidisciplinary Clinic. medRxiv. 2022:prepint. doi: 10.1101/2022.08.03.22278363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.03.22278363</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., Sharma A., Kambhampati S.P., Reddy R.R., Zhang Z., Cleland J.L., Kannan S., Kannan R.M. Scalable Synthesis and Validation of PAMAM Dendrimer- N -Acetyl Cysteine Conjugate for Potential Translation. Bioeng. Transl. Med. 2018;3:87&#x2013;101. doi: 10.1002/btm2.10094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/btm2.10094</ArticleId><ArticleId IdType="pmc">PMC6063872</ArticleId><ArticleId IdType="pubmed">30065965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannan S., Dai H., Navath R.S., Balakrishnan B., Jyoti A., Janisse J., Romero R., Kannan R.M. Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model. Sci. Transl. Med. 2012;4:130ra46. doi: 10.1126/scitranslmed.3003162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3003162</ArticleId><ArticleId IdType="pmc">PMC3492056</ArticleId><ArticleId IdType="pubmed">22517883</ArticleId></ArticleIdList></Reference><Reference><Citation>Thuan N.H., Shrestha A., Trung N.T., Tatipamula V.B., Van Cuong D., Canh N.X., Van Giang N., Kim T., Sohng J.K., Dhakal D. Advances in Biochemistry and the Biotechnological Production of Taxifolin and Its Derivatives. Biotech. Appl. Biochem. 2022;69:848&#x2013;861. doi: 10.1002/bab.2156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bab.2156</ArticleId><ArticleId IdType="pubmed">33797804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.-H., Wang W.-Y., Chang C.-C., Liou K.-T., Sung Y.-J., Liao J.-F., Chen C.-F., Chang S., Hou Y.-C., Chou Y.-C., et al. Taxifolin Ameliorates Cerebral Ischemia-Reperfusion Injury in Rats through Its Anti-Oxidative Effect and Modulation of NF-Kappa B Activation. J. Biomed. Sci. 2006;13:127&#x2013;141. doi: 10.1007/s11373-005-9031-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11373-005-9031-0</ArticleId><ArticleId IdType="pubmed">16283433</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.Y., Kim H.Y., Park H.J., Shin H.K., Hong K.W., Kim C.D. Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of &#x3b2;-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-&#x39a;B/BACE1 Signaling Pathways. PLoS ONE. 2016;11:e0168286. doi: 10.1371/journal.pone.0168286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168286</ArticleId><ArticleId IdType="pmc">PMC5158044</ArticleId><ArticleId IdType="pubmed">27977755</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunil C., Xu B. An Insight into the Health-Promoting Effects of Taxifolin (Dihydroquercetin) Phytochemistry. 2019;166:112066. doi: 10.1016/j.phytochem.2019.112066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phytochem.2019.112066</ArticleId><ArticleId IdType="pubmed">31325613</ArticleId></ArticleIdList></Reference><Reference><Citation>Varlamova E.G., Khabatova V.V., Gudkov S.V., Plotnikov E.Y., Turovsky E.A. Cytoprotective Properties of a New Nanocomplex of Selenium with Taxifolin in the Cells of the Cerebral Cortex Exposed to Ischemia/Reoxygenation. Pharmaceutics. 2022;14:2477. doi: 10.3390/pharmaceutics14112477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14112477</ArticleId><ArticleId IdType="pmc">PMC9697510</ArticleId><ArticleId IdType="pubmed">36432668</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlansky S., Sallinger M., Grabmayr H., Humer C., Bernhard A., Fahrner M., Frischauf I. Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies. Cells. 2022;11:253. doi: 10.3390/cells11020253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11020253</ArticleId><ArticleId IdType="pmc">PMC8773957</ArticleId><ArticleId IdType="pubmed">35053369</ArticleId></ArticleIdList></Reference><Reference><Citation>DE Flora S., Balansky R., LA Maestra S. Antioxidants and COVID-19. J. Prev. Med. Hyg. 2021;62((Suppl. 3)):E34&#x2013;E45. doi: 10.15167/2421-4248/jpmh2021.62.1S3.1895.</Citation><ArticleIdList><ArticleId IdType="doi">10.15167/2421-4248/jpmh2021.62.1S3.1895</ArticleId><ArticleId IdType="pmc">PMC8452284</ArticleId><ArticleId IdType="pubmed">34622082</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaerunnisa S., Kurniawan H., Awaluddin R., Suhartati S., Soetjipto S. Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study. Med. Pharmacol. 2020:preprint. doi: 10.20944/preprints202003.0226.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202003.0226.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekiou O., Bouziane I., Frissou N., Bouslama Z., Honcharova O., Djemel A., Benselhoub A. In-Silico Identification of Potent Inhibitors of COVID-19 Main Protease (Mpro) from Natural Products. IJBP. 2020;5:000189. doi: 10.23880/IJBP-16000189.</Citation><ArticleIdList><ArticleId IdType="doi">10.23880/IJBP-16000189</ArticleId></ArticleIdList></Reference><Reference><Citation>Utomo R.Y., Ikawati M., Meiyanto E. Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection. Med. Pharmacol. 2020:preprint. doi: 10.20944/preprints202003.0214.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202003.0214.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallei T.E., Tumilaar S.G., Niode N.J., Fatimawali, Kepel B.J., Idroes R., Effendi Y., Sakib S.A., Emran T.B. Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study. Scientifica. 2020;2020:6307457. doi: 10.1155/2020/6307457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6307457</ArticleId><ArticleId IdType="pmc">PMC7773461</ArticleId><ArticleId IdType="pubmed">33425427</ArticleId></ArticleIdList></Reference><Reference><Citation>Adem &#x15e;., Eyupoglu V., Ibrahim I.M., Sarfraz I., Rasul A., Ali M., Elfiky A.A. Multidimensional in Silico Strategy for Identification of Natural Polyphenols-Based SARS-CoV-2 Main Protease (Mpro) Inhibitors to Unveil a Hope against COVID-19. Comput. Biol. Med. 2022;145:105452. doi: 10.1016/j.compbiomed.2022.105452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2022.105452</ArticleId><ArticleId IdType="pmc">PMC8957318</ArticleId><ArticleId IdType="pubmed">35364308</ArticleId></ArticleIdList></Reference><Reference><Citation>Debnath K., Jana N.R., Jana N.R. Quercetin Encapsulated Polymer Nanoparticle for Inhibiting Intracellular Polyglutamine Aggregation. ACS Appl. Bio Mater. 2019;2:5298&#x2013;5305. doi: 10.1021/acsabm.9b00518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsabm.9b00518</ArticleId><ArticleId IdType="pubmed">35021530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopa&#x144;ska M., Batoryna M., Bartman P., Szczygielski J., Bana&#x15b;-Z&#x105;bczyk A. Disorders of the Cholinergic System in COVID-19 Era&#x2014;A Review of the Latest Research. IJMS. 2022;23:672. doi: 10.3390/ijms23020672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020672</ArticleId><ArticleId IdType="pmc">PMC8775685</ArticleId><ArticleId IdType="pubmed">35054856</ArticleId></ArticleIdList></Reference><Reference><Citation>Richetti S.K., Blank M., Capiotti K.M., Piato A.L., Bogo M.R., Vianna M.R., Bonan C.D. Quercetin and Rutin Prevent Scopolamine-Induced Memory Impairment in Zebrafish. Behav. Brain Res. 2011;217:10&#x2013;15. doi: 10.1016/j.bbr.2010.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2010.09.027</ArticleId><ArticleId IdType="pubmed">20888863</ArticleId></ArticleIdList></Reference><Reference><Citation>Palle S., Neerati P. Quercetin Nanoparticles Attenuates Scopolamine Induced Spatial Memory Deficits and Pathological Damages in Rats. Bull. Fac. Pharmacy Cairo Univ. 2017;55:101&#x2013;106. doi: 10.1016/j.bfopcu.2016.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bfopcu.2016.10.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano A., Ettcheto M., Chang J.-H., Barroso E., Espina M., K&#xfc;hne B.A., Barenys M., Auladell C., Folch J., Souto E.B., et al. Dual-Drug Loaded Nanoparticles of Epigallocatechin-3-Gallate (EGCG)/Ascorbic Acid Enhance Therapeutic Efficacy of EGCG in a APPswe/PS1dE9 Alzheimer&#x2019;s Disease Mice Model. J. Control. Release. 2019;301:62&#x2013;75. doi: 10.1016/j.jconrel.2019.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2019.03.010</ArticleId><ArticleId IdType="pmc">PMC6510952</ArticleId><ArticleId IdType="pubmed">30876953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Jin L., Wu Z., Xie Y., Zhang P., Wang Q., Yan S., Chen B., Liang H., Naman C.B., et al. PLGA-PEG Nanoparticles Facilitate In Vivo Anti-Alzheimer&#x2019;s Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown Algae. J. Agric. Food Chem. 2021;69:9764&#x2013;9777. doi: 10.1021/acs.jafc.1c00569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.1c00569</ArticleId><ArticleId IdType="pubmed">34404210</ArticleId></ArticleIdList></Reference><Reference><Citation>Moussa C., Hebron M., Huang X., Ahn J., Rissman R.A., Aisen P.S., Turner R.S. Resveratrol Regulates Neuro-Inflammation and Induces Adaptive Immunity in Alzheimer&#x2019;s Disease. J. Neuroinflamm. 2017;14:1. doi: 10.1186/s12974-016-0779-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0779-0</ArticleId><ArticleId IdType="pmc">PMC5234138</ArticleId><ArticleId IdType="pubmed">28086917</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Q., Hu P., Xu Y., Cheng T., Wei C., Pan L., Shi J. Simultaneous Blood&#x2013;Brain Barrier Crossing and Protection for Stroke Treatment Based on Edaravone-Loaded Ceria Nanoparticles. ACS Nano. 2018;12:6794&#x2013;6805. doi: 10.1021/acsnano.8b01994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.8b01994</ArticleId><ArticleId IdType="pubmed">29932327</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakoti A.S., Singh S., Kumar A., Malinska M., Kuchibhatla S.V.N.T., Wozniak K., Self W.T., Seal S. PEGylated Nanoceria as Radical Scavenger with Tunable Redox Chemistry. J. Am. Chem. Soc. 2009;131:14144&#x2013;14145. doi: 10.1021/ja9051087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja9051087</ArticleId><ArticleId IdType="pmc">PMC3038119</ArticleId><ArticleId IdType="pubmed">19769392</ArticleId></ArticleIdList></Reference><Reference><Citation>He L., Su Y., Lanhong J., Shi S. Recent Advances of Cerium Oxide Nanoparticles in Synthesis, Luminescence and Biomedical Studies: A Review. J. Rare Earths. 2015;33:791&#x2013;799. doi: 10.1016/S1002-0721(14)60486-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1002-0721(14)60486-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzigalinski B.A., Carfagna C.S., Ehrich M. Cerium Oxide Nanoparticles in Neuroprotection and Considerations for Efficacy and Safety. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2017;9:e1444. doi: 10.1002/wnan.1444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wnan.1444</ArticleId><ArticleId IdType="pmc">PMC5422143</ArticleId><ArticleId IdType="pubmed">27860449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesana M., Erlichman J.S., Andreescu S. Real-Time Monitoring of Superoxide Accumulation and Antioxidant Activity in a Brain Slice Model Using an Electrochemical Cytochrome c Biosensor. Free Radic. Biol. Med. 2012;53:2240&#x2013;2249. doi: 10.1016/j.freeradbiomed.2012.10.540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.10.540</ArticleId><ArticleId IdType="pmc">PMC3565046</ArticleId><ArticleId IdType="pubmed">23085519</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez A.Y., Pritchard S., Harper K., Aston J.W., Lynch A., Lucky J.J., Ludington J.S., Chatani P., Mosenthal W.P., Leiter J.C., et al. Neuroprotective Mechanisms of Cerium Oxide Nanoparticles in a Mouse Hippocampal Brain Slice Model of Ischemia. Free Radic. Biol. Med. 2011;51:1155&#x2013;1163. doi: 10.1016/j.freeradbiomed.2011.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.06.006</ArticleId><ArticleId IdType="pubmed">21704154</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R., Sun S., Yang J., Long W., Wang J., Mu X., Li Q., Hao W., Zhang S., Liu H., et al. Nanozyme-Based Bandage with Single-Atom Catalysis for Brain Trauma. ACS Nano. 2019;13:11552&#x2013;11560. doi: 10.1021/acsnano.9b05075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.9b05075</ArticleId><ArticleId IdType="pubmed">31553878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon H.J., Cha M.-Y., Kim D., Kim D.K., Soh M., Shin K., Hyeon T., Mook-Jung I. Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer&#x2019;s Disease. ACS Nano. 2016;10:2860&#x2013;2870. doi: 10.1021/acsnano.5b08045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.5b08045</ArticleId><ArticleId IdType="pubmed">26844592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.K., Kim T., Choi I.-Y., Soh M., Kim D., Kim Y.-J., Jang H., Yang H.-S., Kim J.Y., Park H.-K., et al. Ceria Nanoparticles That Can Protect against Ischemic Stroke. Angew. Chem. Int. Ed. 2012;51:11039&#x2013;11043. doi: 10.1002/anie.201203780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201203780</ArticleId><ArticleId IdType="pubmed">22968916</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S., Ma C., Zhu M.-Q., Ju W.-N., Yang Y., Wang X. Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer&#x2019;s Disease. Front. Cell. Neurosci. 2020;14:21. doi: 10.3389/fncel.2020.00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00021</ArticleId><ArticleId IdType="pmc">PMC7058693</ArticleId><ArticleId IdType="pubmed">32184709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Wang Z., Li X., Wang L., Yin M., Wang L., Chen N., Fan C., Song H. Dietary Iron Oxide Nanoparticles Delay Aging and Ameliorate Neurodegeneration in Drosophila. Adv. Mater. 2016;28:1387&#x2013;1393. doi: 10.1002/adma.201503893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.201503893</ArticleId><ArticleId IdType="pubmed">26643597</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiyama Y., Higuchi M., Zhang B., Huang S.-M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M.-Y. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model. Neuron. 2007;53:337&#x2013;351. doi: 10.1016/j.neuron.2007.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.01.010</ArticleId><ArticleId IdType="pubmed">17270732</ArticleId></ArticleIdList></Reference><Reference><Citation>Glat M., Skaat H., Menkes-Caspi N., Margel S., Stern E.A. Age-Dependent Effects of Microglial Inhibition in Vivo on Alzheimer&#x2019;s Disease Neuropathology Using Bioactive-Conjugated Iron Oxide Nanoparticles. J. Nanobiotechnol. 2013;11:32. doi: 10.1186/1477-3155-11-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-3155-11-32</ArticleId><ArticleId IdType="pmc">PMC3851539</ArticleId><ArticleId IdType="pubmed">24059692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirsadeghi S., Shanehsazzadeh S., Atyabi F., Dinarvand R. Effect of PEGylated Superparamagnetic Iron Oxide Nanoparticles (SPIONs) under Magnetic Field on Amyloid Beta Fibrillation Process. Mater. Sci. Eng. C. 2016;59:390&#x2013;397. doi: 10.1016/j.msec.2015.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msec.2015.10.026</ArticleId><ArticleId IdType="pubmed">26652388</ArticleId></ArticleIdList></Reference><Reference><Citation>Katebi S., Esmaeili A., Ghaedi K., Zarrabi A. Superparamagnetic Iron Oxide Nanoparticles Combined with NGF and Quercetin Promote Neuronal Branching Morphogenesis of PC12 Cells. IJN. 2019;14:2157&#x2013;2169. doi: 10.2147/IJN.S191878.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S191878</ArticleId><ArticleId IdType="pmc">PMC6445231</ArticleId><ArticleId IdType="pubmed">30992663</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung T.-H., Hsu S.-C., Wu S.-H., Hsiao J.-K., Lin C.-P., Yao M., Huang D.-M. Dextran-Coated Iron Oxide Nanoparticle-Improved Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Parkinson&#x2019;s Disease. Nanoscale. 2018;10:2998&#x2013;3007. doi: 10.1039/C7NR06976F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7NR06976F</ArticleId><ArticleId IdType="pubmed">29372743</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta J., Fatima M.T., Islam Z., Khan R.H., Uversky V.N., Salahuddin P. Nanoparticle Formulations in the Diagnosis and Therapy of Alzheimer&#x2019;s Disease. Int. J. Biol. Macromol. 2019;130:515&#x2013;526. doi: 10.1016/j.ijbiomac.2019.02.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2019.02.156</ArticleId><ArticleId IdType="pubmed">30826404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes S.V., Walczak P., Janowski M., Reis R.L., Silva-Correia J., Oliveira J.M. Cytocompatible Manganese Dioxide-Based Hydrogel Nanoreactors for MRI Imaging. Biomater. Adv. 2022;134:112575. doi: 10.1016/j.msec.2021.112575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msec.2021.112575</ArticleId><ArticleId IdType="pubmed">35525742</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A.S. Green Synthesis of Nanocrystalline Manganese (II, III) Oxide. Mater. Sci. Semicond. Process. 2017;71:342&#x2013;347. doi: 10.1016/j.mssp.2017.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mssp.2017.08.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoseinpour V., Ghaemi N. Green Synthesis of Manganese Nanoparticles: Applications and Future Perspective&#x2013;A Review. J. Photochem. Photobiol. B Biol. 2018;189:234&#x2013;243. doi: 10.1016/j.jphotobiol.2018.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphotobiol.2018.10.022</ArticleId><ArticleId IdType="pubmed">30412855</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira D.R., Tapeinos C., Rebelo A.L., Oliveira J.M., Reis R.L., Pandit A. Scavenging Nanoreactors That Modulate Inflammation. Adv. Biosys. 2018;2:1800086. doi: 10.1002/adbi.201800086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adbi.201800086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Adjei I.M., Brown S.B., Liseth O., Sharma B. Manganese Dioxide Nanoparticles Protect Cartilage from Inflammation-Induced Oxidative Stress. Biomaterials. 2019;224:119467. doi: 10.1016/j.biomaterials.2019.119467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2019.119467</ArticleId><ArticleId IdType="pmc">PMC7025913</ArticleId><ArticleId IdType="pubmed">31557589</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira C.A., Ni D., Rosenkrans Z.T., Cai W. Scavenging of Reactive Oxygen and Nitrogen Species with Nanomaterials. Nano Res. 2018;11:4955&#x2013;4984. doi: 10.1007/s12274-018-2092-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12274-018-2092-y</ArticleId><ArticleId IdType="pmc">PMC6233906</ArticleId><ArticleId IdType="pubmed">30450165</ArticleId></ArticleIdList></Reference><Reference><Citation>Omid H., Oghabian M.A., Ahmadi R., Shahbazi N., Hosseini H.R.M., Shanehsazzadeh S., Zangeneh R.N. Synthesizing and Staining Manganese Oxide Nanoparticles for Cytotoxicity and Cellular Uptake Investigation. Biochim. Et Biophys. Acta (BBA) Gen. Subj. 2014;1840:428&#x2013;433. doi: 10.1016/j.bbagen.2013.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2013.10.001</ArticleId><ArticleId IdType="pubmed">24112973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuthati Y., Busa P., Goutham Davuluri V.N., Wong C.S. Manganese Oxide Nanozymes Ameliorate Mechanical Allodynia in a Rat Model of Partial Sciatic Nerve-Transection Induced Neuropathic Pain. IJN. 2019;14:10105&#x2013;10117. doi: 10.2147/IJN.S225594.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S225594</ArticleId><ArticleId IdType="pmc">PMC6938959</ArticleId><ArticleId IdType="pubmed">31920306</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N., Savanur M.A., Srivastava S., D&#x2019;Silva P., Mugesh G. A Manganese Oxide Nanozyme Prevents the Oxidative Damage of Biomolecules without Affecting the Endogenous Antioxidant System. Nanoscale. 2019;11:3855&#x2013;3863. doi: 10.1039/C8NR09397K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8NR09397K</ArticleId><ArticleId IdType="pubmed">30758009</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao J., Cheng Y., Zhou M., Zhao S., Lin S., Wang X., Wu J., Li S., Wei H. ROS Scavenging Mn3O4 Nanozymes for in Vivo Anti-Inflammation. Chem. Sci. 2018;9:2927&#x2013;2933. doi: 10.1039/C7SC05476A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7SC05476A</ArticleId><ArticleId IdType="pmc">PMC5915792</ArticleId><ArticleId IdType="pubmed">29732076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tootoonchi M.H., Hashempour M., Blackwelder P.L., Fraker C.A. Manganese Oxide Particles as Cytoprotective, Oxygen Generating Agents. Acta Biomater. 2017;59:327&#x2013;337. doi: 10.1016/j.actbio.2017.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actbio.2017.07.006</ArticleId><ArticleId IdType="pubmed">28688986</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley J.W. Bioavailability of Selenium from Foods. Nutr. Rev. 2006;64:146&#x2013;151. doi: 10.1111/j.1753-4887.2006.tb00198.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1753-4887.2006.tb00198.x</ArticleId><ArticleId IdType="pubmed">16572602</ArticleId></ArticleIdList></Reference><Reference><Citation>Avery J., Hoffmann P. Selenium, Selenoproteins, and Immunity. Nutrients. 2018;10:1203. doi: 10.3390/nu10091203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10091203</ArticleId><ArticleId IdType="pmc">PMC6163284</ArticleId><ArticleId IdType="pubmed">30200430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mal&#x2019;tseva V.N., Goltyaev M.V., Turovsky E.A., Varlamova E.G. Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19. IJMS. 2022;23:2360. doi: 10.3390/ijms23042360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042360</ArticleId><ArticleId IdType="pmc">PMC8880504</ArticleId><ArticleId IdType="pubmed">35216476</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillin O., Vindry C., Ohlmann T., Chavatte L. Selenium, Selenoproteins and Viral Infection. Nutrients. 2019;11:2101. doi: 10.3390/nu11092101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11092101</ArticleId><ArticleId IdType="pmc">PMC6769590</ArticleId><ArticleId IdType="pubmed">31487871</ArticleId></ArticleIdList></Reference><Reference><Citation>Majeed M., Nagabhushanam K., Gowda S., Mundkur L. An Exploratory Study of Selenium Status in Healthy Individuals and in Patients with COVID-19 in a South Indian Population: The Case for Adequate Selenium Status. Nutrition. 2021;82:111053. doi: 10.1016/j.nut.2020.111053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.111053</ArticleId><ArticleId IdType="pmc">PMC7657009</ArticleId><ArticleId IdType="pubmed">33321395</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghaddam A., Heller R., Sun Q., Seelig J., Cherkezov A., Seibert L., Hackler J., Seemann P., Diegmann J., Pilz M., et al. Selenium Deficiency Is Associated with Mortality Risk from COVID-19. Nutrients. 2020;12:2098. doi: 10.3390/nu12072098.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072098</ArticleId><ArticleId IdType="pmc">PMC7400921</ArticleId><ArticleId IdType="pubmed">32708526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.-C., Lee N.-H., Patel K.D., Jun S.-K., Park J.-H., Knowles J.C., Kim H.-W., Lee H.-H., Lee J.-H. A Study on Myogenesis by Regulation of Reactive Oxygen Species and Cytotoxic Activity by Selenium Nanoparticles. Antioxidants. 2021;10:1727. doi: 10.3390/antiox10111727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10111727</ArticleId><ArticleId IdType="pmc">PMC8615179</ArticleId><ArticleId IdType="pubmed">34829599</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicente-Zurdo D., Rodr&#xed;guez-Bl&#xe1;zquez S., G&#xf3;mez-Mej&#xed;a E., Rosales-Conrado N., Le&#xf3;n-Gonz&#xe1;lez M.E., Madrid Y. Neuroprotective Activity of Selenium Nanoparticles against the Effect of Amino Acid Enantiomers in Alzheimer&#x2019;s Disease. Anal. Bioanal. Chem. 2022;414:7573&#x2013;7584. doi: 10.1007/s00216-022-04285-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-022-04285-z</ArticleId><ArticleId IdType="pubmed">35982253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdavi M., Mavandadnejad F., Yazdi M.H., Faghfuri E., Hashemi H., Homayouni-Oreh S., Farhoudi R., Shahverdi A.R. Oral Administration of Synthetic Selenium Nanoparticles Induced Robust Th1 Cytokine Pattern after HBs Antigen Vaccination in Mouse Model. J. Infect. Public Health. 2017;10:102&#x2013;109. doi: 10.1016/j.jiph.2016.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2016.02.006</ArticleId><ArticleId IdType="pubmed">27026241</ArticleId></ArticleIdList></Reference><Reference><Citation>Takamiya M., Miyamoto Y., Yamashita T., Deguchi K., Ohta Y., Abe K. Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice. Neuroscience. 2012;221:47&#x2013;55. doi: 10.1016/j.neuroscience.2012.06.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.06.060</ArticleId><ArticleId IdType="pubmed">22766232</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu X., Wang J., Li Y., Xu F., Long W., Ouyang L., Liu H., Jing Y., Wang J., Dai H., et al. Redox Trimetallic Nanozyme with Neutral Environment Preference for Brain Injury. ACS Nano. 2019;13:1870&#x2013;1884. doi: 10.1021/acsnano.8b08045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.8b08045</ArticleId><ArticleId IdType="pubmed">30753061</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert D., Dargusch R., Raitano J., Chan S.-W. Cerium and Yttrium Oxide Nanoparticles Are Neuroprotective. Biochem. Biophys. Res. Commun. 2006;342:86&#x2013;91. doi: 10.1016/j.bbrc.2006.01.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.01.129</ArticleId><ArticleId IdType="pubmed">16480682</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaganathan S., John A.A., Vellayappan M.V., Balaji A., Mohandas H., Subramanian A.P. Carbon Nanotubes and Graphene as Emerging Candidates in Neuroregeneration and Neurodrug Delivery. IJN. 2015;ume 10:4267&#x2013;4277. doi: 10.2147/IJN.S83777.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S83777</ArticleId><ArticleId IdType="pmc">PMC4495782</ArticleId><ArticleId IdType="pubmed">26170663</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobylev A.G., Marsagishvili L.G., Podlubnaya Z.A. Fluorescence Analysis of the Action of Soluble Derivatives of Fullerene C60 on Amyloid Fibrils of the Brain Peptide A&#x3b2;(1&#x2013;42) Biophysics. 2010;55:699&#x2013;702. doi: 10.1134/S0006350910050027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006350910050027</ArticleId><ArticleId IdType="pubmed">21033342</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y., Wang Z., Owens A.C.E., Kulaots I., Chen Y., Kane A.B., Hurt R.H. Antioxidant Chemistry of Graphene-Based Materials and Its Role in Oxidation Protection Technology. Nanoscale. 2014;6:11744&#x2013;11755. doi: 10.1039/C4NR03275F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4NR03275F</ArticleId><ArticleId IdType="pmc">PMC4312421</ArticleId><ArticleId IdType="pubmed">25157875</ArticleId></ArticleIdList></Reference><Reference><Citation>Petro M., Jaffer H., Yang J., Kabu S., Morris V.B., Labhasetwar V. Tissue Plasminogen Activator Followed by Antioxidant-Loaded Nanoparticle Delivery Promotes Activation/Mobilization of Progenitor Cells in Infarcted Rat Brain. Biomaterials. 2016;81:169&#x2013;180. doi: 10.1016/j.biomaterials.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2015.12.009</ArticleId><ArticleId IdType="pmc">PMC4715952</ArticleId><ArticleId IdType="pubmed">26735970</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrabi S.S., Yang J., Gao Y., Kuang Y., Labhasetwar V. Nanoparticles with Antioxidant Enzymes Protect Injured Spinal Cord from Neuronal Cell Apoptosis by Attenuating Mitochondrial Dysfunction. J. Control. Release. 2020;317:300&#x2013;311. doi: 10.1016/j.jconrel.2019.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2019.12.001</ArticleId><ArticleId IdType="pmc">PMC7007870</ArticleId><ArticleId IdType="pubmed">31805339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox K.H., Pipingas A., Scholey A.B. Investigation of the Effects of Solid Lipid Curcumin on Cognition and Mood in a Healthy Older Population. J. Psychopharmacol. 2015;29:642&#x2013;651. doi: 10.1177/0269881114552744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881114552744</ArticleId><ArticleId IdType="pubmed">25277322</ArticleId></ArticleIdList></Reference><Reference><Citation>Fidelis E.M., Savall A.S.P., da Luz Abreu E., Carvalho F., Teixeira F.E.G., Haas S.E., Bazanella Sampaio T., Pinton S. Curcumin-Loaded Nanocapsules Reverses the Depressant-Like Behavior and Oxidative Stress Induced by &#x3b2;-Amyloid in Mice. Neuroscience. 2019;423:122&#x2013;130. doi: 10.1016/j.neuroscience.2019.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2019.09.032</ArticleId><ArticleId IdType="pubmed">31698022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang L., Dong X., Yang J. Influence of Nanoparticle-Loaded Edaravone on Postoperative Effects in Patients with Cerebral Hemorrhage. J. Nanosci. Nanotechnol. 2021;21:1202&#x2013;1211. doi: 10.1166/jnn.2021.18668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1166/jnn.2021.18668</ArticleId><ArticleId IdType="pubmed">33183463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashafaq M., Intakhab Alam M., Khan A., Islam F., Khuwaja G., Hussain S., Ali R., Alshahrani S., Antar Makeen H., Alhazmi H.A., et al. Nanoparticles of Resveratrol Attenuates Oxidative Stress and Inflammation after Ischemic Stroke in Rats. Int. Immunopharmacol. 2021;94:107494. doi: 10.1016/j.intimp.2021.107494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107494</ArticleId><ArticleId IdType="pubmed">33676175</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurana I., Allawadhi P., Khurana A., Srivastava A.K., Navik U., Banothu A.K., Bharani K.K. Can Bilirubin Nanomedicine Become a Hope for the Management of COVID-19? Med. Hypotheses. 2021;149:110534. doi: 10.1016/j.mehy.2021.110534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110534</ArticleId><ArticleId IdType="pmc">PMC7881296</ArticleId><ArticleId IdType="pubmed">33640714</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitan E., Hutchison E.R., Greig N.H., Tweedie D., Celik H., Ghosh S., Fishbein K.W., Spencer R.G., Sasaki C.Y., Ghosh P., et al. Combination Therapy with Lenalidomide and Nanoceria Ameliorates CNS Autoimmunity. Exp. Neurol. 2015;273:151&#x2013;160. doi: 10.1016/j.expneurol.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC4644463</ArticleId><ArticleId IdType="pubmed">26277686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulker D., Abacioglu N., Sehirli A.O. Cerium Oxide (CeO2) Nanoparticles Could Have Protective Effect Against COVID-19. Lett. Appl. NanoBioScience. 2022;12:12. doi: 10.33263/LIANBS121.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.33263/LIANBS121.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey Z.S., Nilson E., Bates J.A., Oyalowo A., Hockey K.S., Sajja V.S.S.S., Thorpe C., Rogers H., Dunn B., Frey A.S., et al. Cerium Oxide Nanoparticles Improve Outcome after In Vitro and In Vivo Mild Traumatic Brain Injury. J. Neurotrauma. 2020;37:1452&#x2013;1462. doi: 10.1089/neu.2016.4644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2016.4644</ArticleId><ArticleId IdType="pmc">PMC7249477</ArticleId><ArticleId IdType="pubmed">27733104</ArticleId></ArticleIdList></Reference><Reference><Citation>Klyachko N.L., Manickam D.S., Brynskikh A.M., Uglanova S.V., Li S., Higginbotham S.M., Bronich T.K., Batrakova E.V., Kabanov A.V. Cross-Linked Antioxidant Nanozymes for Improved Delivery to CNS. Nanomed. Nanotechnol. Biol. Med. 2012;8:119&#x2013;129. doi: 10.1016/j.nano.2011.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nano.2011.05.010</ArticleId><ArticleId IdType="pmc">PMC3255173</ArticleId><ArticleId IdType="pubmed">21703990</ArticleId></ArticleIdList></Reference><Reference><Citation>Manickam D.S., Brynskikh A.M., Kopanic J.L., Sorgen P.L., Klyachko N.L., Batrakova E.V., Bronich T.K., Kabanov A.V. Well-Defined Cross-Linked Antioxidant Nanozymes for Treatment of Ischemic Brain Injury. J. Control. Release. 2012;162:636&#x2013;645. doi: 10.1016/j.jconrel.2012.07.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2012.07.044</ArticleId><ArticleId IdType="pmc">PMC3597468</ArticleId><ArticleId IdType="pubmed">22902590</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal A., Morris V.B., Labhasetwar V., Ghorpade A. Nanoparticle-Mediated Catalase Delivery Protects Human Neurons from Oxidative Stress. Cell Death Dis. 2013;4:e903. doi: 10.1038/cddis.2013.362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.362</ArticleId><ArticleId IdType="pmc">PMC3847304</ArticleId><ArticleId IdType="pubmed">24201802</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy M.K., Wu L., Kou W., Ghorpade A., Labhasetwar V. Superoxide Dismutase-Loaded PLGA Nanoparticles Protect Cultured Human Neurons Under Oxidative Stress. Appl. Biochem. Biotechnol. 2008;151:565&#x2013;577. doi: 10.1007/s12010-008-8232-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12010-008-8232-1</ArticleId><ArticleId IdType="pmc">PMC2670226</ArticleId><ArticleId IdType="pubmed">18509606</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>